|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/65 | |
| A61K 38/27 | |||
| A61K 38/30 | |||
| A61P 5/06 |
| (11) | Patento numeris | 1901770 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 06784529.7 |
| Europos patento paraiškos padavimo data | 2006-06-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2008-03-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-12-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2006/021282 |
| Data | 2006-06-01 |
| (87) | Numeris | WO 2006/130769 |
| Data | 2006-12-07 |
| (30) | Numeris | Data | Šalis |
| 687617 P | 2005-06-02 | US |
| (72) |
CLARK, Ross G., NZ
|
| (73) |
Ipsen Biopharmaceuticals, Inc.,
106 Allen Road, 3rd Floor, Basking Ridge, NJ 07920,
US
|
| (54) | GH AND IGF-1 FOR TREATMENT OF GROWTH DISORDERS |
| GH AND IGF-1 FOR TREATMENT OF GROWTH DISORDERS |